null

Cytokeratin 18 (KRT18) Rabbit Polyclonal Antibody (CAB1022)

SKU:
CAB1022
Product Type:
Antibody
Reactivity:
Human
Mouse
Rat
Host Species:
Rabbit
Isotype:
IgG
Antibody Type:
Polyclonal Antibody
Research Area:
Cell Cycle
  • Cell Cycle Antibodies 1 Anti-Cytokeratin-18 Antibody CAB1022
  • Cell Cycle Antibodies 1 Anti-Cytokeratin-18 Antibody CAB1022
  • Cell Cycle Antibodies 1 Anti-Cytokeratin-18 Antibody CAB1022
  • Cell Cycle Antibodies 1 Anti-Cytokeratin-18 Antibody CAB1022
€139 - €419
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

Cytokeratin 18 (KRT18) Rabbit Polyclonal Antibody (CAB1022)

The KRT18 Polyclonal Antibody (CAB1022) is a valuable tool for researchers studying keratin 18, a type I intermediate filament protein found in epithelial cells. This antibody, produced using rabbits, exhibits high reactivity with human samples and has been validated for use in Western blotting applications. By binding specifically to KRT18 protein, this antibody enables the detection and analysis of KRT18 in various cell types, making it ideal for studies in cell biology, cancer research, and regenerative medicine.Keratin 18 is known for its role in maintaining the structural integrity of epithelial cells and is often used as a biomarker for epithelial cell differentiation and function. Abnormal expression of KRT18 has been linked to various diseases, including liver disease, pancreatic cancer, and inflammatory disorders.

Therefore, a thorough understanding of KRT18 expression patterns and regulation is crucial for advancing our knowledge of these diseases and developing targeted therapeutics.Researchers utilizing the KRT18 Polyclonal Antibody can benefit from its high specificity and sensitivity in detecting KRT18 protein levels, allowing for precise quantification and analysis in experimental settings. By uncovering the intricate roles of KRT18 in health and disease, this antibody facilitates groundbreaking discoveries and advancements in the field of molecular biology and biomedical research.